logo

For the Inventor, By the Inventor

Ballymena, United Kingdom

Robert Ivan McConnell

USPTO Granted Patents = 19

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 152(Granted Patents)


Location History:

  • Antrim, GB (2001)
  • Ballymena, GB (2005 - 2008)
  • Co. Antrim, GB (2001 - 2010)
  • Co. Antrim, IE (2005 - 2010)
  • Crumlin, GB (2003 - 2015)

Company Filing History:

goldMedal18 out of 96 
 
Randox Laboratories Limited
 patents
silverMedal1 out of 1 
 
Randox :Abpratproes :O, Oted
 patent

Years Active: 2001-2015

Loading Chart...
19 patents (USPTO):Explore Patents
1. 9222949 - Salvinorin immunoassay (2015-12-29),
2. 8673652 - Immunoassay with extended detection window (2014-03-18),
3. 7846713 - Calibrating microarrays (2010-12-07),
4. 7811824 - Method and apparatus for monitoring the properties of a biological or chemical sample (2010-10-12),
5. 7371829 - Haptens, immunogens, antibodies and conjugates to ketamine and its metabolites (2008-05-13),
6. 7217802 - Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine (2007-05-15),
7. 7192722 - Phenethanolamine-derived haptens, immunogens, antibodies and conjugates (2007-03-20),
8. 7115718 - Haptens, immunogens, antibodies and conjugates to 2-oxo-3-hydroxy-LSD (2006-10-03),
9. 7109310 - Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs (2006-09-19),
10. 7026134 - Haptens, immunogens and antibodies to oxycodone and its metabolites (2006-04-11),
11. 6960653 - Method and kit for detecting, or determining the quantity of, beta-lactam penicillins (2005-11-01),
12. 6902897 - Biochip deposition system and method (2005-06-07),
13. 6897026 - Array imaging method (2005-05-24),
14. 6881572 - Assay device incubator (2005-04-19),
15. 6649128 - Assay device processing instrument (2003-11-18),

Title: Innovations and Contributions of Robert Ivan McConnell

Introduction

Robert Ivan McConnell, based in Ballymena, GB, is a prolific inventor with an impressive portfolio of 19 patents. His inventions primarily focus on advancements in immunoassay methods, showcasing his vital contributions to the field of analytical chemistry and biomedical diagnostics.

Latest Patents

Among his latest patents are two significant innovations. The first is the **Salvinorin immunoassay**, which presents a method for detecting or determining the concentration of salvinorin A, salvinorin B, and their analogues in vitro. This invention also encompasses the development of specific antibodies and a detection kit designed for accurate measurement of these compounds in various samples. The second patent, **Immunoassay with extended detection window**, addresses the need for highly sensitive detection methods for the drug zolpidem. This patent includes novel antibodies created from a unique immunogen, allowing for the detection of zolpidem and its main urinary metabolite, hence extending the detection window for individuals who may have abused the drug or suffered from its side effects.

Career Highlights

Robert McConnell's career has seen him associated with notable companies, including Randox Laboratories Limited. His work at Randox reflects his dedication to improving diagnostic methodologies that can benefit healthcare professionals and patients alike.

Collaborations

Throughout his career, McConnell has collaborated with esteemed colleagues such as Stephen Peter Fitzgerald and John Victor Lamont. These collaborations highlight his role within a team of innovators, all striving to advance scientific understanding and application of immunoassay methods in medical diagnostics.

Conclusion

Robert Ivan McConnell stands out as a significant inventor in the realm of immunoassay technology. His 19 patents reflect his relentless pursuit of innovation and commitment to enhancing diagnostic capabilities in the medical field. With continued advancements in his research, McConnell’s contributions are set to have a lasting impact on both science and healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…